LexDanaLexDanabeta
Inventor

Robin D. G. Cooper

Inventor
Indianapolis, IN, US

Overview

50→
Patents
1976–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07KPeptides6%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C07HSugars1%
C40BCombinatorial chemistry1%
PatentTitleYear
10,421,752Compositions and methods for inhibition of the JAK pathway20199,732,073'Compositions and methods for inhibition of the JAK pathway'20179,481,654'Compositions and methods for inhibition of the JAK pathway'20169,248,190'Compositions and methods for inhibition of the JAK pathway'20169,040,543'Compositions and methods for inhibition of the JAK pathway'20158,962,643'Compositions and methods for inhibition of the JAK pathway'20158,815,848'Compositions and methods for inhibition of the JAK pathway'20148,729,087'Compositions and methods for inhibition of the JAK pathway'20148,415,365'Compositions and methods for inhibition of the JAK pathway'20138,399,472'Compositions and methods for inhibition of the JAK pathway'20138,304,422'Compositions and methods for inhibition of the JAK pathway'20128,299,087'Compositions and methods for inhibition of the JAK pathway'20128,193,197'Compositions and methods for inhibition of the JAK pathway'20127,947,698'Compositions and methods for inhibition of the JAK pathway'20117,851,480'Spiro 2,4-pyrimidinediamine compounds and their uses'20107,834,024'Compositions and methods for inhibition of the JAK pathway'20107,557,207'Spiro 2,4-pyrimidinediamine compounds and their uses'20097,491,732'Compositions and methods for inhibition of the JAK pathway'20096,908,996'Compounds and method for preparing 3-methylcephams'20056,683,176'Intermediates for and synthesis of 3-methylene cephams'20045,977,062'Glycopeptide antibiotic derivatives'19995,936,074'Teicoplanin deacylation process and product'19995,919,756'Amides'19995,916,873'Teicoplanin derivatives'19995,843,889'Glycopeptide antibiotic derivatives'19985,840,684'Glycopeptide antibiotic derivatives'19985,759,865'Combinatorial process for synthesizing azetidinone analogs'19984,772,694'Chiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediates'19884,734,498'3.beta.-succinimidoazetidinones as chiral intermediates'19884,587,053'Preparation of oxazolines'19864,518,531'Allylic chlorination process and compounds prepared thereby'19854,490,370'Naphthylglycyl cephalosporin derivatives'19844,482,553'Benzothienylglycyl cephalosporin derivatives'19844,468,514'Preparation of 3-bromocephalosporins from thiazoline azetidinones'19844,430,268'Allylic chlorination process'19844,355,172'Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives'19824,243,587'Process for 3.beta.-aminoazetidin-2-ones'19814,226,767'Intermediates for 3-aminoazetidin-2-ones'19804,224,442'7-Ureido acetamido substituted cephalosporin antibiotics'19804,203,896'Acetoxy azetidin-2-one antibiotics via thiazolidine ring cleavage'19804,180,507'4-Oxa 2,6 diazabicycloheptane derivatives'19794,158,004'Process for antibiotic FR 1923 and related compounds'19794,144,232'Substituted azetidin-2-one antibiotics'19794,133,808'4-(Formylthio)azetidinones and ozonization process therefor'19794,127,568'Process for 3.beta.-aminoazetidin-2-ones'19784,115,383'Alkoxycarbonyl-ethylthio-azetidinones and process for their preparation'19784,048,157'4(Formylthio)-azetidin-2-ones and ozonization process therefor'19774,039,535'7-[.alpha.-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICS'19773,956,292'7-(.alpha.-FUROYLUREIDOARYL AND CYCLOHEXADIENYLACETAMIDO) CEPHALOSPORIN ANTIBIOTICS'19763,946,003'Hydroxy substituted phenylglycylamido-3-heterocyclic thiomethyl cephalosporins'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1999Patents assigned to LILLY CO ELI (30)· patent assignee history
1976–2005Based in Indianapolis, IN, US· patent location history
2009–2019Patents assigned to RIGEL PHARMACEUTICALS INC (18)· patent assignee history
2009–2019Based in St. George Island, FL, US· patent location history
2012–2015Patents assigned to BHAMIDIPATI SOMASEKHAR (7)· patent assignee history
2012–2015Patents assigned to CARROLL DAVID (7)· patent assignee history
2012–2015Patents assigned to COOPER ROBIN (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LILLY CO ELI301976–1999
RIGEL PHARMACEUTICALS INC182009–2019
BHAMIDIPATI SOMASEKHAR72012–2015
CARROLL DAVID72012–2015
COOPER ROBINself72012–2015
Locations
LocationPatentsSpan
Indianapolis, IN, US321976–2005
St. George Island, Florida, US182009–2019